Anti-Hu CD79b PerCP-Cy1535.5

Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Dry Ice Shipment: No

Alternative Products

Cat	Name
MBS1800493-02	Anti-Hu CD79b PerCP-Cyanine5.5
MBS1800493-01	Anti-Hu CD79b PerCP-Cyanine5.5
MBS1800491-01	Anti-Hu CD79b FITC
MBS1800489-01	Anti-Hu CD79b Purified
MBS1800490-01	Anti-Hu CD79b APC
MBS1800490-02	Anti-Hu CD79b APC
MBS1800489-02	Anti-Hu CD79b Purified
MBS1800491-02	Anti-Hu CD79b FITC
MBS1800492-01	Anti-Hu CD79b PE
MBS1800492-02	Anti-Hu CD79b PE

CAT:

270-T9-676-T025

Size:

25 Tests

Price:

Ask

For price, please contact [email protected].

Anti-Hu CD79b PerCP-Cy1535.5

Clone: CB3-1
Format: PerCP-Cy1535.5
Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations: *Nakamura T, Kubagawa H, Cooper MD: Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci U S A. 1992 Sep 1589(18):8522-6., URL: https://www.ncbi.nlm.nih.gov/pubmed/1382292,*Zheng B, Fuji RN, Elkins K, Yu SF, Fuh FK, Chuh J, Tan C, Hongo JA, Raab H, Kozak KR, Williams M, McDorman E, Eaton D, Ebens A, Polson AG: In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates. Mol Cancer Ther. 2009 Oct8(10):2937-46., URL: https://www.ncbi.nlm.nih.gov/pubmed/19808977,*Garcia Vela J, Delgado I, Benito L, Monteserin M, Garcia Alonso L, Somolinos N, Andreu M, Oña F: CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection. Leukemia. 1999 Oct13(10):1501-5., URL: https://www.ncbi.nlm.nih.gov/pubmed/10516749,*Rassenti LZ, Kipps TJ: Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion. Blood. 2000 Apr 1595(8):2725-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/10753858,*Dornan D, Bennett F, Chen Y, Dennis M, Eaton D, Elkins K, French D, Go MA, Jack A, Junutula JR, Koeppen H, Lau J, McBride J, Rawstron A, Shi X, Yu N, Yu SF, Yue P, Zheng B, Ebens A, Polson AG: Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma. Blood. 2009 Sep 24114(13):2721-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/19633198,*Matutes E: New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Clin Pathol. 2002 Mar55(3):180-3., URL: http://www.ncbi.nlm.nih.gov/pubmed/11896067 ,*D'Arena G, Cascavilla N, Musto P, Colella Bisogno R, Pistolese G, Carotenuto M: CD79b expression in B-cell chronic lymphocytic leukemia. Haematologica. 2000 May85(5):556-7., URL: http://www.ncbi.nlm.nih.gov/pubmed/10800181 ,

Complementary Product Range

Our range of products, including Anti-Hu CD79b PerCP-Cy1535.5, falls within the same field of application and can be used across various research projects. These products are carefully selected for their high performance and reliability, supporting the diverse needs of modern laboratories. Whether for ongoing studies or future experiments, they are designed to help researchers achieve their scientific goals. Here are some related products that may be of interest for similar or future applications:

Each item in our collection, is tested for precision and quality, ensuring dependable solutions for your research. As we continue to incorporate the latest advancements, Gentaur ensures that our product range remains relevant and versatile, providing you with the tools needed for both current and future projects.

Find us on

Cat	Name
T9-676-T025	Anti-Hu CD79b PerCP-Cy1535.5
T9-676-T100	Anti-Hu CD79b PerCP-Cy1535.5
T9-138-T100	Anti-Hu CD15 PerCP-Cy1535.5
T9-160-T100	Anti-Hu CD45 PerCP-Cy1535.5
T9-176-T100	Anti-Hu CD279 PerCP-Cy1535.5
T9-209-T025	Anti-Hu CD10 PerCP-Cy1535.5
T9-223-T100	Anti-Hu CD45RA PerCP-Cy1535.5
T9-235-T100	Anti-Hu CD71 PerCP-Cy1535.5
T9-293-T025	Anti-Hu CD14 PerCP-Cy1535.5
T9-308-T100	Anti-Hu CD27 PerCP-Cy1535.5